- Home
- ILMN vs PNR Comparison
ILMN vs PNR Comparison
Compare ILMN & PNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- PNR
- Stock Information
- Founded
- ILMN 1998
- PNR 1966
- Country
- ILMN United States
- PNR United Kingdom
- Employees
- ILMN N/A
- PNR N/A
- Industry
- ILMN Medical Specialities
- PNR Industrial Machinery/Components
- Sector
- ILMN Health Care
- PNR Industrials
- Exchange
- ILMN Nasdaq
- PNR Nasdaq
- Market Cap
- ILMN 18.9B
- PNR 17.4B
- IPO Year
- ILMN 2000
- PNR N/A
- Fundamental
- Price
- ILMN $123.26
- PNR $104.94
- Analyst Decision
- ILMN Hold
- PNR Buy
- Analyst Count
- ILMN 15
- PNR 14
- Target Price
- ILMN $114.93
- PNR $119.57
- AVG Volume (30 Days)
- ILMN 2.1M
- PNR 1.2M
- Earning Date
- ILMN 10-30-2025
- PNR 10-21-2025
- Dividend Yield
- ILMN N/A
- PNR 0.99%
- EPS Growth
- ILMN N/A
- PNR N/A
- EPS
- ILMN 4.46
- PNR 3.93
- Revenue
- ILMN $4,288,000,000.00
- PNR $4,128,399,999.00
- Revenue This Year
- ILMN N/A
- PNR $2.97
- Revenue Next Year
- ILMN $2.22
- PNR $4.64
- P/E Ratio
- ILMN $27.76
- PNR $26.66
- Revenue Growth
- ILMN N/A
- PNR 0.83
- 52 Week Low
- ILMN $68.70
- PNR $74.25
- 52 Week High
- ILMN $153.06
- PNR $113.95
- Technical
- Relative Strength Index (RSI)
- ILMN 64.52
- PNR 44.64
- Support Level
- ILMN $117.86
- PNR $101.38
- Resistance Level
- ILMN $126.94
- PNR $109.89
- Average True Range (ATR)
- ILMN 4.62
- PNR 2.41
- MACD
- ILMN -0.31
- PNR -0.41
- Stochastic Oscillator
- ILMN 66.58
- PNR 43.29
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About PNR Pentair plc.
Pentair is a global leader in the water treatment industry, with 10,000 employees and a presence in 25 countries. Its business is organized into three segments: pool, water technologies, and flow. The company offers a wide range of water solutions, including energy-efficient swimming pool equipment, filtration solutions, and commercial and industrial pumps. Pentair generated approximately $4.1 billion in revenue in 2024.